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  W
ith more than 6 million HIV 
positive individuals—the 
highest of any country in the 
world—South Africa is the epicentre 
of the HIV/AIDS pandemic. In much 
of sub-Saharan Africa, especially South 
Africa, the HIV/AIDS epidemic is 
growing fastest in teenagers, especially 
young girls (see sidebar) [1]. Hence, 
any future vaccination strategy in this 
setting will, of necessity, have to target 
young adolescents prior to sexual 
debut. 
    The current candidate HIV vaccines 
that are being considered for efﬁ  cacy 
trials are likely to act principally by 
reducing viral loads, hence reducing 
both transmission to sexual partners 
and progression to AIDS [2]. One 
of the limitations to conducting 
HIV vaccine trials is the dearth 
of data on important HIV disease 
parameters such as viral load, immune 
responses, and disease progression 
in African adolescents. While there is 
observational research currently being 
conducted in the United States on 
adolescents, such as the Reaching for 
Excellence in Adolescent Care and 
Health (REACH) study [3], there is a 
need for information on set point, HIV 
transmission, and disease progression 
in adolescents from Africa, even if only 
to conﬁ  rm whether the disease process 
in African adolescents differs from 
those in developed countries.
    The Joint United Nations 
Programme on HIV/AIDS notes 
that children, including infants and 
adolescents, should be eligible for 
enrolment in HIV preventive vaccine 
trials, both as a matter of equity 
and because young adolescents 
and children are at high risk of 
HIV infection [4]. However, no 
distinction is drawn between adolescent 
participation with parental consent 
and the autonomous participation 
of adolescents. This distinction is 
particularly important in sub-Saharan 
Africa, where it is often difﬁ  cult or 
impossible to obtain parental consent. 
    The Centre for the AIDS 
Programme of Research in South 
Africa (CAPRISA), which is funded by 
the US National Institutes of Health, 
recently proposed a follow-up study 
of adolescents and young adults with 
acute HIV infection to obtain the 
essential information on subtype C 
viral set point, prognostic viral load 
measurements, and disease outcome—
all important biological outcome 
markers in HIV vaccine efﬁ  cacy trials. 
The study proposed to enrol, as one 
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  The Critical Need to Study 
Young Adolescent Women
    The rapid spread of HIV among 
young women, and particularly among 
adolescent girls in South Africa, has been 
described as “explosive” [1]. Year 2005 
estimates of HIV incidence among South 
African youth aged 15–24 years is 3.3% 
[9]. Alarmingly, females in this age group 
have a ﬁ  ve-times-higher HIV incidence 
than males (6.1% versus 0.8%) [9]. In 
addition to the public health imperative 
to reduce HIV risk in this age group, a 
deeper understanding of the factors 
inﬂ  uencing HIV risk in adolescent girls is 
critical for altering the nature and course 
of the epidemic in sub-Saharan Africa. 
    In one rural South African district, the 
prevalence of HIV infection in pregnant 
women increased from 26% in 2001 
to 34% in 2002 [8]. Importantly, 39% 
of the pregnant women in this district 
were younger than 19 years of age, with 
the youngest being 12 years of age. In 
pregnant women younger than 19 years 
of age, the HIV prevalence was 25.8%, 
and the incidence rate is estimated 
to be as high as 9.6% per annum. HIV 
prevalence among girls younger than 19 
years attending family planning clinics in 
this district was 27.5% in 2002. The sheer 
scale of the epidemic in this one rural 
district highlights the critical need for HIV 
prevention, treatment, and research in 
adolescents. PLoS Medicine  |  www.plosmedicine.org 0985
of its groups, adolescents as young 
as 14 years old from a prenatal and 
family planning clinic, where those 
who volunteered could do so without 
parental consent when parents or 
legal guardians were not available. 
Three ethics committees supported 
the enrolment of this cohort, although 
a fourth did not. As a result, the study 
protocol was amended to include 
participants only above the age of 18. 
    Several works have highlighted the 
ethico-legal challenges implicit in 
enrolling adolescents in South African 
HIV vaccine trials [5–7]. However, the 
enrolment of autonomous adolescents 
in crucial HIV observational studies 
and in other types of sensitive non-
HIV research in South Africa is 
equally problematic. We present the 
ethico-legal challenges, as well as 
the scientiﬁ  c and social grounds, to 
justify the autonomous participation 
of adolescents in HIV observational 
studies—such as the CAPRISA study—
as well as in future HIV vaccine trials 
in South Africa and much of the rest 
of sub-Saharan Africa. We argue that 
the same reasoning applies to other 
types of sensitive non-HIV research 
involving adolescents. We also suggest 
how conﬂ  icts between restrictive laws 
and ﬂ  exible ethics guidelines should be 
addressed.
  Social  Considerations:  Obstacles 
to Parental Consent 
    The Human Sciences Research Council 
reports an almost 2-fold increase in 
South African households headed 
by children or consisting only of 
children (referred to as “child-headed 
households”, i.e., orphans or children 
without resident adult guardians) 
between 2002 [8] and 2005 [9]. In the 
2005 study, among children 12–18 years 
of age, 2.6% (or 180,433) identiﬁ  ed 
themselves as heads of households, 
with the majority being African. Among 
orphans 12–18 years of age, 2.8% (or 
213,859) identiﬁ  ed themselves as being 
heads of households. The 2005 Human 
Sciences Research Council study also 
highlighted statistics that indicate 
that almost 65% of orphans live in 
community or family care, or child-
headed households. 
    Our data supports these ﬁ  ndings 
and show that many of the adolescents 
attending the prenatal and family 
planning clinics do not live with their 
parents [10]. Some live alone, either 
because their parents are deceased 
or because they work and live in a 
distant urban area. Others have been 
left in the care of members of the 
community (usually relatives). Most 
of these surrogate caregivers are not 
formally appointed or recognised as 
the child’s legal guardian. In these 
instances, it is practically impossible to 
seek parental consent or to determine 
who, if anyone, is the legal guardian to 
authorise an adolescent’s participation 
in a study.
  Ethical  Considerations
    According to the Council for the 
International Organisation of Medical 
Sciences Guidelines, “In some 
jurisdictions, individuals who are below 
the general age of consent are regarded 
as ‘emancipated’ or ‘mature’ minors 
and are authorized to consent without 
the agreement or even the awareness 
of their parents or guardians” (see 
commentary on guideline 14 in [11]).
    Prenatal and family planning clinic 
attendees are often selected for 
enrolment into HIV studies because 
they are sexually active, often times 
have multiple partners, and are already 
familiar with clinical procedures. Given 
the observations on child-headed 
households above, there are good 
grounds to consider such adolescents as 
“mature minors”, as this recognises the 
social reality of the study population. 
Acknowledgment of this reality makes 
it unnecessary to seek supplemental 
parental consent for adolescent 
participation in studies. 
    On the issue of mature minors and 
the need to obtain additional parental 
informed consent, the Council for 
the International Organisation of 
Medical Sciences Guidelines state 
the following: “Some studies involve 
investigation of adolescents’ beliefs and 
behaviour regarding sexuality or use 
of recreational drugs; other research 
addresses domestic violence or child 
abuse. For studies on these topics, 
ethical review committees may waive 
parental permission if, for example, 
parental knowledge of the subject 
matter may place the adolescents 
at some risk of questioning or even 
intimidation by their parents” (see 
commentary on guideline 14 in [11]).
    An HIV-positive test result often 
carries a negative connotation and 
stigma. Discrimination, violence, and 
social ostracism are often experienced 
by those, especially women, who 
disclose their HIV status to partners 
and family members. There is also the 
concern that adolescents are not willing 
to participate if their HIV status will 
be disclosed to their parents. In such 
cases, parents may want to be informed 
of their children’s HIV status by 
researchers and health-care providers 
even if it is against their children’s 
wishes, thereby violating the study 
participant’s right to conﬁ  dentiality. 
As a serious consequence of violating 
this right, participants could be 
inadvertently deterred from seeking 
necessary treatment, a decision that 
would have adverse consequences for 
their health. 
    The researcher’s willingness to 
respect an adolescent participant’s 
autonomy and right to conﬁ  dentiality 
will likely determine that adolescent 
individual’s willingness to participate 
in research. Adolescent participants 
would enrol in such studies on the 
legitimate expectation that their 
conﬁ  dentiality would be respected. 
Requiring these participants to seek 
parental consent for their participation 
in the study would effectively nullify 
this obligation to assure conﬁ  dentiality. 
Moreover, researchers or health-care 
providers who breach the adolescent 
participant’s conﬁ  dentiality to parents 
could violate section 14 of South 
Africa’s Constitution [12], which 
entitles everyone (including minors) to 
the right of privacy.
    In some countries, such as the US, 
ethical review committees have the 
authority to waive a requirement for 
parental permission for adolescent 
participation when there are 
compelling reasons warranting this 
action. Yet, despite the merits of doing 
so, ethical review committees in South 
DOI: 10.1371/journal.pmed.0030180.g001
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Africa have been hesitant, not only 
for adolescents of 14 years of age, 
but even for adolescents of 16 and 17 
years of age. This is compounded by 
the current ethico-legal position in 
South Africa, where the current South 
African Medical Research Council 
(MRC) research ethics guidelines 
(General Principles) prescribe 14 
years of age as the autonomous age 
of consent for therapeutic research 
but not observational studies [13]. 
The General Principles stipulate 
that therapeutic research may be 
undertaken with the independent 
consent of a minor over the age of 14. 
It regards the pursuit of additional 
parental consent in such instances as 
“desirable” but not mandatory. On 
the issue of nontherapeutic research 
(including observational research of 
a nontherapeutic nature, such as the 
CAPRISA study, which may involve 
invasive procedures such as blood 
draws), the General Principles provide 
that such research in the context of 
adolescents is generally not permissible, 
except where parental consent (and 
the assent of the minor concerned) is 
obtained. The General Principles state 
that “…where the research is of such 
a nature that there is no possibility of 
harm to the child, either physically 
or psychologically, the minor may 
consent independently, provided he 
is intellectually of sufﬁ  cient maturity 
to understand the nature of the 
procedure and to give voluntary, 
informed consent. As a general rule it 
may be assumed that a child below the 
age of 14 is not of such maturity” [14]. 
    The General Principles also contain 
many other ﬂ  aws and inconsistencies in 
regard to research on adolescents [15]. 
In short, the General Principles are 
counter to the interests of adolescents. 
They fail to acknowledge that the 
acquisition of additional parental 
or guardian consent would, in some 
instances, (1) be logistically impossible, 
(2) necessitate breaching the 
conﬁ  dentiality of research participants, 
and (3) place the participant at 
potential risk of harm. These concerns 
also apply to adolescents involved in 
sensitive non-HIV-related research. 
Although the MRC has issued more 
ﬂ  exible ethics guidelines on HIV 
vaccine research [14], these guidelines 
do not apply to research sponsored 
by agencies other than the MRC, and 
they are not applicable to observational 
research. While South Africa’s Good 
Clinical Practice Guidelines [16] also 
offer guidance on adolescent research, 
they, too, do not govern observational 
research. So how can following 
the General Principles affect HIV 
observational studies?
    Our work in a rural part of South 
Africa has revealed that adolescents, 
some as young as 12 years old, routinely 
seek antenatal care, treatment for 
sexually transmitted infections, or 
family planning at district clinics. 
They do so autonomously, despite 
the legal age for consent to treatment 
being 14 years of age, and, perhaps, 
they do so because they do not have 
parents or legal guardians or because 
they perceive that conﬁ  dentiality 
is assured. These factors no doubt 
motivate adolescents to present at 
clinics for treatment in other settings, 
too. Following the guidance of the 
General Principles for adolescent 
research attached to such clinics 
will make such research impossible. 
Although the General Principles are, 
strictly speaking, only binding on MRC-
sponsored studies, they are generally 
considered inﬂ  uential among members 
of South Africa’s research ethics 
community. 
    Matters will be compounded when 
the country’s newly promulgated 
National Health Act (NHA) becomes 
operational. The NHA mandates the 
solicitation of parental consent for 
adolescent enrolment in therapeutic 
and nontherapeutic studies, as well 
as ministerial consent in the case of 
nontherapeutic studies. The NHA does 
not prescribe deﬁ  nitions for the terms 
“child” and “minor”, although it uses 
both terms interchangeably in relation 
to both types of studies, which is 
problematic since there is no uniform 
deﬁ  nition for these terms in South 
African law [17]. 
    In May 2005, South Africa issued its 
ﬁ  rst national health research ethics 
guidelines intended to govern all 
health-related research in the country. 
Entitled Ethics in Health Research: 
Principles, Structures and Processes 
(EHR), the document describes itself 
as the country’s “national policy on 
the ethical practice of research”, and 
makes explicitly clear that its principles 
should guide “all research involving 
animals and human participants in 
any discipline relating to health” 
[18]. The EHR is intended to be 
read in conjunction with the relevant 
provisions in the NHA that govern 
research. However, some of its 
provisions are incompatible with the 
NHA.
    Paragraph 5.1 of the EHR governs 
research on minors. It begins 
by declaring that minors should 
participate in research “only where 
their participation is indispensable to 
the research and where participation is 
not contrary to the individual minor’s 
best interests”. In terms of the EHR, 
“child” is taken to mean a person who 
has not yet reached puberty, while 
“adolescent” means a person who has 
reached puberty. The EHR’s glossary 
section, which bases its deﬁ  nitions on 
the Canadian Code of Ethical Conduct 
for Research Involving Humans (1996) 
and the International Conference on 
Harmonisation Guidelines for Good 
Clinical Practice, deﬁ  nes “child” slightly 
differently. It provides that a child “is 
a minor who lacks the legal ability to 
make a decision whether or not to 
participate in research”. Despite its 
explicit reference to the law, the EHR, 
like the NHA, steers clear of providing 
a legal deﬁ  nition of the term “minor”. 
However, unlike the NHA, which does 
not recognise the rights of children to 
autonomously participate in research 
in any circumstance, the EHR adopts a 
ﬂ  exible approach that seemingly puts 
it at odds with the NHA. It recognises 
that “adolescents may be capable of 
consenting themselves to certain types 
of research participation and that, for 
particular types of research, it may be 
desirable that they do so unassisted”. 
In this regard, the EHR can be said to 
be more responsive to South Africa’s 
increasing social reality of “mature 
minors” and child-headed households. 
    The EHR also seems to have 
heeded the concerns of investigators 
participating in sensitive research 
involving adolescents, who voiced 
their concerns about the inﬂ  exibility 
of the NHA on this issue. Paragraph 
5.3.1 of the EHR accordingly advises 
research ethics committees (RECs) that 
research involving adolescents who may 
July 2006  |  Volume 3  |  Issue 7  |  e180
 Adolescents’  best 
interests will be served 
by their autonomous 
participation. PLoS Medicine  |  www.plosmedicine.org 0987
consent unassisted should be approved 
only if (1) the research, including 
observational research, places the 
adolescent at no more than minimal 
risk, and only if (2) the nature of the 
research is such that, in the opinion of 
the REC, the parents or legal guardians 
or community at large are unlikely to 
object to the adolescent autonomously 
consenting to participation in the 
investigation. The opinion of the REC 
must be informed by information 
gathered from the community 
concerned and by contributions from 
the lay members of the committee.
    “Minimal risk research”, according to 
the EHR, is that which “anticipates that 
the probability and magnitude of harm 
or discomfort to be experienced in the 
research will not be greater than those 
ordinarily encountered in daily life”. 
This resonates with the understanding 
of the term in the American Code of 
Federal Regulations (45 CFR 46.102). 
The EHR stipulates that in all cases, 
the protocol must provide sufﬁ  cient 
information to justify clearly why 
adolescents should be included as 
participants and must justify clearly 
why the adolescent participants should 
consent unassisted. 
  Conﬂ  icts between the Guidelines 
and the Law: How Should Ethics 
Committees Respond?
    Given that the NHA and EHR take 
different stances on the autonomous 
participation of children in research, 
how should RECs deal with this 
apparent conﬂ  ict? Conventional wisdom 
dictates that provisions of law take 
precedent over provisions in policy or 
guidance documents. However, there 
are at least ﬁ  ve important reasons why a 
REC should embrace the stance of the 
EHR, in regards to research on minors, 
over that of the NHA, notwithstanding 
the latter’s legal nature. 
    First, adhering to the ﬂ  exible 
stance of the EHR will make it 
possible to investigate valuable and 
necessary sexuality-related research on 
adolescents, of the type outlined above. 
    Second, a REC’s primary mandate 
should be to make decisions based on 
ethical considerations versus exclusively 
legal considerations. Blindly following 
ill-considered law could evidence 
unethical and unconstitutional 
outcomes. 
    Third, the EHR was launched by 
the minister of health in the aftermath 
of the promulgation of the NHA and 
the numerous concerns that were 
raised about its provisions pertaining 
to research on minors. It should be 
assumed that the minister applied 
her mind to the issue, realised the 
inconsistency between the NHA and 
the EHR, but gave her unreserved 
endorsement to the latter because 
doing so was in the best interests 
of adolescent minors. To assume 
otherwise would imply that the 
minister did not apply her mind to 
the implications of the EHR before 
approving it. 
    Fourth, as in other countries, 
South African law holds that the best 
interests of the child must dictate 
what approach to follow in matters 
pertaining to a child. Given the 
invaluable biological, sociological, 
behavioural, and clinical data that the 
inclusion of an adolescent cohort will 
generate in HIV studies, the enrolment 
of this cohort is crucial for future 
prevention and treatment interventions 
in this group. Accordingly, the best 
interests of adolescents will be served 
by their autonomous participation in 
such studies. The NHA is intended 
to protect the interests of children. 
RECs should respect the spirit of the 
law rather than merely the letter of 
the law. The interests of children will 
be protected and promoted by their 
participation in minimal risk HIV 
observational studies.
    Fifth, in growing recognition of the 
autonomous decision-making abilities 
of young individuals, South Africa’s 
draft Children’s Bill [19] promises 
to bring sweeping changes to the 
law in regards to children. The bill, 
several years in the making, is the 
most signiﬁ  cant postapartheid legal 
instrument governing the affairs of 
children. Upon promulgation, the 
bill will repeal several key statutes that 
currently govern the affairs of children, 
including the Children’s Act, (Act 33 
of 1960), the Age of Majority Act (Act 
57 of 1972), and the Child Care Act 
(Act 74 of 1983). Part 3 of the bill is 
explicitly dedicated to matters relating 
to the health of children. Section 129 
of the bill governs consent to medical 
treatment of or surgical operation on 
a child. In a break with current law, 
the bill lowers the age of consent for 
medical treatment. It provides that 
children may consent to their own 
medical treatment (or to the medical 
treatment of their child) if over the age 
of 12 years, of sufﬁ  cient maturity, and 
with the mental capacity to understand 
the beneﬁ  ts, risks, and social and other 
implications of the outcome. Similarly, 
the bill also provides that children 
may consent to the performance of 
a surgical operation on themselves 
(or their child) if over the age of 12 
years, of sufﬁ  cient maturity, and with 
the mental capacity to understand the 
beneﬁ  ts, risks, and social and other 
implications of the surgical operation, 
and where duly assisted by their parent 
or guardian. Admittedly, the bill does 
not pertain to research. However, the 
Children’s Bill is a more recent law 
than the NHA, and it overwhelmingly 
demonstrates that the South African 
legislature explicitly recognises that 
adolescents as young as 12 years of 
age are capable of making important 
decisions autonomously, a factor that 
RECs should note. 
    A Proposal for the Way Forward
    As adolescents are bearing the brunt 
of the AIDS epidemic in much of sub-
Saharan Africa, we believe studies in 
this group are critical. We have argued 
that it is ethically justiﬁ  able to enrol 
adolescents in certain cases without 
seeking parental consent for adolescent 
participation in HIV research. The 
same might apply to certain types of 
sensitive non-HIV research involving 
adolescents who could be compromised 
if parental consent was made 
mandatory (for example, research on 
child abuse, teenage pregnancy, and 
teenage sexuality). We accordingly 
encourage local RECs to exercise their 
discretion to authorise the waiver of 
additional parental consent in studies 
involving adolescents on a case-by-case 
basis.
    The research regulatory framework 
of the US—which is much more 
comprehensive than that of South 
Africa or the rest of sub-Saharan 
Africa—could prove instructive. The 
American Code of Federal Regulations 
(45 CFR 46.408c) endorses the waiver 
of parental consent in instances 
where the pursuit of consent could be 
detrimental to the minor (as we have 
argued is applicable in South Africa). 
Ethical review committees should 
also note that regardless of South 
Africa’s lack of uniformity on the legal 
age of majority, the World Health 
Organization Guidelines for Research 
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on Reproductive Health Involving 
Adolescents [20] states that there is no 
clear ethical justiﬁ  cation for excluding 
from research adolescent individuals 
“below the age of legal majority”, and 
that an ethical duty of beneﬁ  cence 
and justice might exist to conduct 
appropriate research on this group. We 
strongly urge ethical review committees 
to consider these persuasive factors in 
pondering the merits of permitting 
autonomous adolescent participation 
in all research on a case-by-case basis. 
    While it is difﬁ  cult to establish truly 
representative community structures 
for consultation on research issues, 
the approach of engaging with the 
communities where the research is 
being conducted could be one part 
of the solution [21,22]. This could 
be done through existing community 
representative bodies or through 
the establishment of a representative 
community structure from the 
intended study population [23]. This 
creates the opportunity to discuss the 
rationale underpinning the inclusion 
of adolescents in the research, as well 
as the reasons for not making parental 
consent for an adolescent’s participation 
in a study a requirement. We believe 
that the social reality of child-headed 
households, as well as community 
endorsement of this approach, should 
factor strongly into a research ethical 
review committee’s consideration in 
its deliberations on whether to allow 
adolescents to provide autonomous 
consent for participation in a study. 
  Conclusion
    We do not believe that the challenges 
that face South African researchers 
in enrolling adolescent participants 
in HIV studies, such as the CAPRISA 
study, are unique to the country. The 
challenges probably apply to much 
of sub-Saharan Africa, where future 
vaccine and microbicide efﬁ  cacy trials 
will need to be conducted if we are 
to fast track efforts to ﬁ  nd a vaccine 
or microbicide to reduce the spread 
of HIV in this important population. 
Moreover, we also believe that the 
factors we argued for in favour of 
the autonomous participation of 
adolescents in HIV-related studies 
apply equally to certain types of 
sensitive non-HIV research. We 
recommend that investigators involved 
in such research endeavours urge the 
ethics committees that oversee their 
research to embrace the stance of the 
EHR over that of the NHA for the 
reasons we outlined above.
    The need to protect adolescents 
from harm in research needs to be 
carefully balanced with the need to 
undertake research in this population 
to ﬁ  nd solutions to this epidemic. 
To this end, rigid legislation and/or 
ethical guidelines that pertain to 
adolescent participation in research 
and their uncritical application are 
counterproductive. We need to be 
cognizant of this inherent conﬂ  ict 
and create an enabling ethico-legal 
framework to avoid inadvertently doing 
more harm than good to the intended 
study population.   
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